GW-501516 vs Ipamorelin for weight loss
Short answer: For weight loss, more users report improvement with Ipamorelin — 93% of 43 reports, versus 85% of 52 for GW-501516.
GW-501516 has 0 meta-analyses and 0 randomized trials on PubMed; Ipamorelin has 0 and 2.
Based on 317 reports about GW-501516 and 378 about Ipamorelin. Not medical advice.
| GW-501516 Substance | Ipamorelin Peptide | |
|---|---|---|
| User score | 48 | 18 |
| Verdict | Mostly positive | Mostly positive |
| Positive of reports that state an outcome | 65% | 63% |
| Reports | 317 | 378 |
| Research | DResearch: None | CResearch: Limited |
| Meta-analyses / RCTs | 0 / 0 | 0 / 2 |
| Mainly used for | ||
| Weight loss % reporting improvement | 85% (52) | 93% (43) |
| Appetite % reporting improvement | 50% (4) | 25% (12) |
| Focus % reporting improvement | — | 100% (5) |
| Energy % reporting improvement | 95% (19) | 88% (17) |
| Sleep % reporting improvement | 0% (2) | 77% (65) |
| Mood % reporting improvement | 100% (2) | 100% (8) |
| Performance % reporting improvement | 93% (75) | 82% (33) |
| Recovery % reporting improvement | 100% (3) | 88% (43) |
| Pain & inflammation % reporting improvement | — | 100% (13) |
| Digestion % reporting improvement | — | 33% (3) |
| Hormones % reporting improvement | — | 72% (18) |
| Blood sugar % reporting improvement | — | 0% (3) |
| Heart & lipids % reporting improvement | 86% (22) | — |
| Skin & hair % reporting improvement | — | 91% (11) |
| Longevity % reporting improvement | 50% (2) | — |
| Common side effects | cancer risk, acne, fatigue, brain fog | insomnia, flushing, water retention, fatigue |
| Typical dose reported | 20 mg / daily | Not listed |
GW-501516Full GW-501516 profile →
What a user said
“For weight loss Cardarine is good. It tells your body to use fat as energy... my body fat has dropped abit but not loads but it's been 2 weeks.”
IpamorelinFull Ipamorelin profile →
What a user said
“CJC-1295, Ipamorelin, rHGH all help. Helped me recover from Phenibut overuse and dependence, and heavy stimulants.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate